Serum concentrations and ex vivo inhibitory/bactericidal activity of clindamycin after administration of two oral dosages

Chemotherapy

Volumn 43, Issue 4, 1997, Pages 227-231

  Dan, M ^a   Yampolsky, E ^a   Poch, F ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Clindamycin; Inhibitory bactericidal activity; Serum; Staphylococcus aureus; Streptococcus pyogenes

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTIVE SURGERY; HUMAN; HUMAN EXPERIMENT; MICROCOCCUS LUTEUS; MINOR SURGERY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TECHNIQUE;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; BLOOD BACTERICIDAL ACTIVITY; CLINDAMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 0030915968     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239571     Document Type: Article

References (10)

1. Falagas ME, Gorbach SL: Clindamycin and metronidazole. Med Clin North Am 1995;79:845-867.
2. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria Which Grow Aerobically; Approved Standards (7-A2), ed 2. Villanova, National Committee for Clinical Laboratory' Standards, 1990.
3. National Committee for Clinical Laboratory Standards: Methodology for the Scrum Bactericidal Test; Tentative Guidelines (M 21-T), ed 2. Villanova, National Committee for Clinical Laboratory Standards, 1992.
4. Novak E: Clindamycin: Clinical pharmacology; in Zambrano D (ed): Clindamycin in the Treatment of Human Infections. Kalamazoo, Upjohn, 1992, pp 2-1-2-13.
5. Lemmen S, Kropec A, Engels I, Busse A, Daschncr FD: MIC and serum bactericidal activity of clindamycin against methicillin-resis-tant and sensitive staphylococcus. Infection 1993;21:407-409.
6. Binso AL, Stevens DL: Streptococcal infections of skin and soft tissue. N Engl J Med 1996;334:240-245.
7. Rodriguez-Noriega E: Clindamycin in the treatment of skin and soft tissue and bone and joint infections; in Zambrano D (ed): Clindamycin in the Treatment of Human Infections. Kalamazoo, Upjohn, 1992, pp 8-1-8-28.
8. Cockburn J. Gibberd RW, Reid AL, Sanson-Fisher RW: Determinants of non-compliance with short term antibiotic regimens. Br Med J 1987; 295:814-818.
9. Gallegos B, Rios A, Espidel A: A double blind multicenter comparative study on two administration regimens of clindamycin hydrochloride in the treatment of acute tonsillitis/pharyngitis. Clin Thcr 1995; 17: 613-621.
10. Baxter R, Chapman J, Drew WL: Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus. J Infect Dis 1990; 161:1023-1025.